View Post The ASSURE Study: HIV-1 Suppression Is Maintained with Bone and Renal Biomarker Improvement 48 Weeks after Ritonavir Discontinuation and Randomized Switch to Abacavir/Lamivudine + Atazanavir. HIV Medicine, 17(2): 106-117. In by AHFFebruary 1, 2016
View Post Provider and Patient Correlates of Provider Decisions to Recommend HCV Treatment to HIV Co-Infected Patients. Journal of the International Association of Physicians in AIDS Care, 11(4): 245-251. In by AHFJanuary 1, 2012
View Post Hepatitis C Patients’ Self-Reported Adherence to Treatment with Pegylated Interferon and Ribavirin. Alimentary Pharmacology and Therapeutics, 28: 289-293. In by AHFJuly 1, 2008
View Post The Safety and Efficacy of Dose-Sparing Intradermal Administration of Influenza Vaccine in Human Immunodeficiency Virus–Positive Patients. Archives of Internal Medicine, (166)13: 1417. In by AHFJuly 1, 2006
View Post Interaction Between Atazanavir and Fosamprenavir in the Treatment of HIV-Infected Patients. Journal of Acquired Immune Deficiency Syndromes, 41(1): 124-125. In by AHFJanuary 1, 2006
View Post Pilot Study of Directly Observed Therapy in Highly Nonadherent HIV-Infected Patients in an Urban Community-Based Institution. Journal of Acquired Immune Deficiency Syndromes, 33(5): 651-653. In by AHFAugust 1, 2003
